ACE and COVID-19: It has been proposed that, in cases of COVID-19, blood platelet activation may be dysregulated via alterations in the function of angiotensin converting enzyme (ACE), and by changes in the angiotensin II/angiotensin type 1 receptor: a G-protein coupled receptor [8,40].